Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
-
Episode 1: Industry Contributions and Collaborations in Parkinson's Research with Karoly Nikolich
-
Episode 0: The Parkinson's Research Landscape and the Role of MJFF with Brian Fiske and Mark Frasier
-
-
MJFF Bio-Hackathon Brings Research Teams Together to Tackle Alpha-synuclein Post-Translational Modifications in Parkinson’s
-
More Biomarker Developments: New Blood Biomarker Measures Mitochondrial Damage in Parkinson’s
-
-
Global Coalition Discovers Gene Variant that Increases Parkinson’s Risk among People of African Descent
![Close-up portrait](/sites/default/files/styles/ad_callout_double/public/images/ad/Final%20PPMI%20House%20ad%201.jpg?h=67cac1bc&itok=UpGUPbo7)
Join the Study that's Changing Everything
The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.
![Michael J. Fox in blue sweater posing for the camera.](/sites/default/files/styles/ad_callout_double/public/images/ad/our-promise-404---Large-Image-Callout-A-2.jpg?h=abb05436&itok=NfaXwL73)
Patients First
Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."